Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly by Bruijn, I.A. (Iris) de et al.
ELSEVIER PII: SO264-41OX(9’7)00019-4 
t&cone, Vol. 15. No. 12/l 3, pp. 1323- 1329, 1997 
0 1997 Elsevier Science Ltd. All rights reserved 
Printed m Great Britain 
0264-410X197 $17+0.00 
Annually repeated influenza 
vaccination improves humoral 
responses to several influenza virus 
strains in healthy elderly 
Iris A. de Bruijn*T, Edmond J. Remarque”, Walter E. Ph. Beyer’f, 
Saskia le Cessie$, Nit Masurelt and Gerard J. Ligthart*§ 
The benefit of annually repeated influenza vaccination on antibody formation is still 
under debate. In this study the effect of annually repeated influenza vaccination on 
haemagglutination inhibiting (HI) antibody formation in the elderly is investigated. 
Between 1990 and 1993 healthy young and elderly, both selected by the SENIEUR 
protocol, were vaccinated consecutively with commercially available influenza vaccines. 
The elderly had a lower HI antibody response after one vaccination as compared to the 
young against the AITaiwanlll86 (Hl Nl), BIYamagatall6/88 and BIPanamaJ45/90 
strains. Annually repeated vaccination did not result in a decrease of the HI antibody 
titres against the A and B vaccine strains in both age groups. Moreover the elderly had 
a sigificant[v higher HI titre against the B strains after the second vaccination as 
compared to the first, resulting in comparable HI titres for young and elderly. Thus, 
annually repeated vaccination has a benejicial effect on the antibody titre against 
injluenza virus and can contribute to a better antibody-response in the elderly. 0 1997 
Elsetier Science Ltd. 
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In many countries annual vaccination against influenza 
is recommended for the elderly and the chronically ill’, 
as it reduces influenza-associated morbidity and 
mortality in these groups’-‘. Because the antigenic 
make-up of the influenza virus changes frequently and 
antibody titres may decline to non-protective levels 
within a year after vaccination’. annual vaccination 
seems needed. 
However, there are conflicting data on the benefit of 
annually repeated influenza vaccination and little is 
known about repeated vaccination in the elderly over 
75 years of age. Hoskins et al.” found a decreased 
protection in boys at a boarding school that had been 
vaccinated annually in comparison with boys that had 
been vaccinated only once. In some studies postvacci- 
nation serum haemagglutination inhibiting (HI) 
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antibody levels were similar in previously vaccinated 
and unvaccinated subjects’-“‘. whereas other studies 
showed significantly lower antibody responses in 
previously vaccinated subjects”,“. 
Studies on annually repeated influenza vaccination 
were often performed in children and young 
adults7.‘.‘.‘J, but influenza epidemics have the greatest 
morbidity and mortality in the elderly”, not only in 
those with underlying disease but also in apparently 
healthy subjects’h-‘x. Underlying disease”.‘“, use of drugs 
and ageing in itself influences the immune response to 
influenza’“,” and progressive diseases or deterioration 
can bias longitudinal studies. Therefore we measured 
the HI antibody titre for 4 years of annually repeated 
influenza vaccination in optimally healthy young and 
elderly who fulfilled the SENIECJR criteria” throughout 
the study. 
MATERIALS AND METHODS 
Subjects 
Between 1990 and 1993 young and elderly persons 
volunteered to receive an annual influenza vaccination, 
with new volunteers entering the study each year. Both 
age groups were selected according to the SENIEUR 
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protocol”, by which strict admission criteria for 
immunogerontological studies in man arc established. 
The protocol is based on clinical and laboratory data 
and it sets limits to pharmacological interference and 
discasc influcnccs. Elderly subjects meeting the 
SIZNI~I!K criteria will hcrcaftcr bc named SLNILIJKS and 
the young JUNII~CJKS. The numbers and demographics 
of the volunteers arc listed in 7&t& 1. All the SLNILNK 
subjects were indepcndcntly living in the city 01 
Lcidcn. the Netherlands. All the JLINIL:UK volunteers 
were students or laboratory staff in the city of Leidcn, 
the Netherlands. All subjects gave informed consent 
and the study was approved by the Medical Ethics 
Committee of Lcidcn University. 
To minimize biases which usually lead to an undcr- 
estimation of the immune response in the elderly, the 
study was performed according to the criteria formu- 
lated by Bcyer et u/.“. Subjects with previous influenza 
vaccinations in the 2years prccceding the study wcrc 
excluded. Priming diffcrcnccs were taken into account 
in the intcrprctation of the data and a statistical 
correction for prcvaccination titrc was applied where 
appropriate. 
Vaccines 
Throughout the study commercially available 
vaccines according to WHO recommendations were 
used (Influvac “, Solvay Duphar b.v., Wccsp. The 
Netherlands) (7&h/e 1). For the IYYO- IYYI season a 
whole virus vaccine was used, containing IS clg 
haemagglutinin for the A strains A/Taiwan/l/X6 
(HIN I) and A/GuizhouA4/89 (H3N2) and 10 11g 
haemagglutinin for the B strains B/Beijing/l/X7 and 
B/Yamagatall6/88. For the seasons I YYI - I YY2 and 
1992-1993 subunit virus vaccines wcrc used containing 
I5 ~-(g hacmagglutinin for each strain. In IYYI the 
vaccine contained the A strains A/Taiwan/l/X6 (HINl) 
and A/Beijing/353/XY (H3N2) and the B strains 
B/Beijing/l/X7 and B/Panama/45/YO. In the lYY2-lYY3 
season the vaccine consisted of the strains A/Taiwan/ 
1186 (HINI). AiBcijingi353iXY (H3N3) and 
B/Yamagata/l6/88. In the lYY3-lYY4 season. only 
S~NIIXJRS were vaccinated. The vaccine contained the 
Table 1 Vaccination of subjects 
strains A/Taiwan/l/86 (HINI). A/Beijing/32192 (H3N2) 
and BiPanamai45190. 
Serological analysis 
Haemagglutination inhibition titres wcrc assessed in 
scra obtained prior to and 21 days after vaccination. HI 
antibody titres were determined following standard 
procedures using chicken erythrocytes and four 
HA-units of the virus”. Influenza B strains were cthcr 
treated”. Pre- and postvaccination sera were titrated 
simultaneously and the sera were analysed in duplicate 
for antibody against all vaccine strains. HI tests were 
performed at the WHO National Influenza Centre for 
the Netherlands. 
Serological protection rates were calculated to 
cxtrapolatc the HI titre to a measure of protection. In 
accordance to the HI test used, a titrc of 100 U was 
taken as a protcctivc level for the influenza A 
strains”.“’ and a titre of 200 for the influenza B 
strains“‘. 
Statistical analysis 
All calculations were performed on ‘log-transformed 
data. Mean HI titres are displayed as geometric mean 
titres (GMT). All statistical procedures were 
performed with SPSSTM for WindowsTM v. 6.1 (SPSS 
inc.. Chicago, USA). Increase of GMT HI antibody 
after the first vaccination was analysed with the paired 
Student’s I-test. Differences between JUNIEUR and 
St:~~tun subjects after the first vaccination regarding 
the prevaccination titrc were analysed with analysis of 
variance (ANOVA). Postvaccination titres were 
analysed with analysis of covariance (ANCOVA) with 
postvaccination titre as the dcpcndent variable and 
prevaccination titrc as the covariate. Where appro- 
priatc, an adjustment for the prcvaccination titre was 
applied. 
To investigate the longitudinal changes in prevacci- 
nation and postvaccination titres after repeated vaccin- 
ation, pairwise comparison of the SENIEUK and 
JLINIWK pre- and postvaccination titres of two conscc- 
utive years was performed with the paired Student’s 
t-test. The differences of prc- and postvaccination titres 
Year of vaccination: N (mean age i S.D.) 
1990 1991 1992 1993 
JUNIEURS 43 (22 * 3) 18 (22 i 2) 9 (22i2) 
SENIEURS 57 (80 k 3) 40 (79i3) 26 (77 i 3) 12 (77k3) 
JUNIEURS 42 (23i5) 14 (23i4) 
SENIEURS 55 (79 i_ 3) 28 (79 k 3) 17 (78f2) 
JUNIEURS 38 (22 i 4) 
SENIEURS 26 (78 i 3) 13 (79i2) 
HlNl 
H3N2 
Bl 
82 
A/Taiwan/l 186 A/Taiwan/l 186 
(15 /rg HA) (15 /rg HA) 
A/Guizhou/54/89 A/Beijing/353189 
(15 ,(g HA) (15 /rg HA) 
Bi’famagatall6188 B/Panama/45190 
(10 /‘g HA) (15 i/g HA) 
B/Beijing/l 187 B/Beijing/l/87 
(10 ,rg HA) (15 /lg HA) 
A/Taiwan/l I86 
(15,lg HA) 
A/Beijing/353189 
(15 ,(g HA) 
BNamagatall6l88 
(15 i/g HA) 
ATTaiwan/ I86 
(15 ,tg HA) 
A/Beijing/32/92 
(15 ,(g HA) 
B/Panama/45/90 
(15 ifs HA) 
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between SENIEUK and JCJNIEUK subjects after repeated 
vaccination were evaluated with the Student’s t-test. 
Differences in serological protection rates between 
SENIUJRS and JUNIEURS were analysed by the x2 test. 
Serological protection rates of two consecutive years 
were analyscd by the McNemar test. 
RESULTS 
HI titre after single vaccination 
The prevaccination HI titres of SENIEURS and 
JUNIEURS were similar for most strains. However, 
prevaccination titres were significantly lower in the 
SENIEURS than in the JUNILXJRS to the A/Taiwan/l/86 
(HlNl) strain in 1YYl and 1992 (P=O.O03 and 
P = 0.001, respectively, ANOVA) and the B/Yamagata/ 
16/X8 strain in 1992 (P = 0.046, ANOVA) (T&k 2). 
Each year JCINICUR and S~NIEUR subjects who were 
vaccinated for the first time showed a significant rise in 
HI titre 21 days after vaccination against all influenza 
strains contained in the vaccine (P<O.OOl for all 
strains, paired Student’s t-test) (Table 2). 
Compared to the JUNIEURS, the SENIEURS had signi- 
ficantly lower postvaccination HI titres against the 
H 1Nl vaccine strain in all three years (PcO.05 for all 
years, ANCOVA). The postvaccination HI titrcs 
against the H3N2 vaccine strains were similar for the 
two age groups in all three years. The postvaccination 
titres against the influenza B strain components of the 
vaccine were significantly lower in the SENIEUKS than in 
the J~JNIELJRS (P<O.Ol for all strains, ANCOVA). with 
the exception of the B/Beijing/l/87 vaccine strain in 
1990 for which there was no significant difference 
between the age groups (T&k 2). 
HI titres after annually repeated vaccination 
Previously vaccinated JUNIEURS and SENIHJRS had 
significantly higher prevaccination titres than previously 
unvaccinated subjects (P<O.Ol for all strains, Student’s 
t-test). Previously vaccinated subjects showed a signifi- 
cant rise in the HI titre 21 days after revaccination 
against the influenza strains contained in the vaccine 
(P<O.OOl for all strains, paired Student’s r-test) 
(Tuhk 2). 
After repeated vaccination prc- and postvaccination 
HI titres of SENIELJRS against the HlNl vaccine 
component (A/Taiwanl1/86) remained lower than the 
HI titres of JUNIEURS (P<O.O5, Student’s t-test), except 
for the postvaccination titre in 1992 where there was 
no difference between the age groups. In both age 
groups HI postvaccination titrcs against the HlNl 
strain did not change after annually repeated vaccina- 
tion in comparison with the postvaccination titre 
reached after one vaccination. Only S~NIEURS who 
entered the study in 1991 had significantly higher post- 
vaccination HI titres after the second vaccination in 
comparison with the first (P<O.Ol, paired Student’s 
t-test), whereas after the third vaccination in 1993 the 
HI postvaccination titre decreased again significantly 
(P (0.01, paired Student’s r-test) but remained higher 
than the postvaccination titre after one vaccination 
(Table 2). 
During the study three different H3N2 components 
had been contained in the vaccine. After repeated 
vaccination the prc- and postvaccination titres against 
the H3N2 vaccine subtypes were largely comparable 
for the two age groups. Repeated vaccination with the 
H3N2 vaccine strains did not result in a decline of the 
postvaccination HI titrc. The SENIEURS who started in 
101 had a higher postvaccination titrc against the 
vaccine strain A/Beijing/32192 in lYY3 in comparison 
with the postvaccination titre against thc.yaccinc strain 
A/Bcijing/353/8Y in l9Y2 (P < 0.05. paired Student’s 
t-test) (7khfc 2). 
The postvaccination HI titres against the B strains 
B/Yamagata/l6/88 and BlPanamal45iYO were lower in 
the SLNIEIJKS after the first vaccination as compared to 
the JUNIEIIRS (P<O.O5, Student’s r-test). After the 
second vaccination the postvaccination titres of the two 
age groups wcrc not different anymore (Tuhk 2). 
SENIEUKS and JUNI~XIKS who started in 1990 had a 
signiticantly higher postvaccination titre after the 
second vaccination as compared to the first (P<O.Ol. 
paired Student’s t-test). After the third vaccination in 
1992 the HI titre against the vaccine strain decreased 
again (SENIUIRS P = 0.002 and J~JNI~UKS P = 0.03, 
paired Student’s t-test) but remained higher than the 
titre after the first vaccination. For the S~NIWRS, the 
fourth vaccination in 1993 resulted in a significant 
increase of the HI titre (P = 0.003. paired Student’s 
r-test) to a level comparable to the HI titre after the 
second vaccination. A diminished postvaccination titre 
in 1992 was not seen against the B/Panama/45/90 
strain, which was the vaccine strain of the previous year 
(data not shown). 
SENIELIKS who started in 1991 or 1992 also had an 
increase of postvaccination HI titre after the second 
vaccination as compared to the previous year (P = 0.02 
and P < 0.0 1. respectively, paired Student’s t-test). The 
HI postvaccination titre of the SENI~~JRS from 1991 
increased even more after a third vaccination in 1993 
as compared to 1992 (P = 0.002, paired Student’s 
t-test). JUNIEURS who started in 1991 showed no signifi- 
cant changes in postvaccination titrc after repeated 
vaccination. The B/Beijing/l/87 strain had only been in 
the vaccine for two consecutive years. No differences 
between JUNIEUKS and S~NIIXJRS were observed after 
repeated vaccination and there was no change in HI 
postvaccination titre level after the second vaccination 
(Tnhk 2). 
Serological protection rates after annually repeated 
vaccination 
The serological protection rates for the B strains 
were increased after the second vaccination in both age 
groups in comparison with the first vaccination 
(P~0.04. McNemar), for the other strains there was no 
change (E&k 3). Similar to the pattern of HI post- 
vaccination titres after repeated vaccination, the 
SENIEUKS from 1990 had a decreased serological 
protection rate to B/Yamagata/16/88 after the third 
vaccination in lY92 as compared to the serological 
protection rate to B/Panama/45/90 in 1991. but after 
the fourth vaccination in l9Y3 the serological protcc- 
tion rate to B/Panama/45190 again increased signiti- 
cantly (P = 0.001, McNemar) (7X& 3). A decrease of 
serological protection rate was not seen against the 
B/Panama/45190 strain. which was the vaccine strain of 
the previous year (data not shown). 
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Serological protection rates against the HI N I rates for the H3N2 and B components of the vaccine 
component of the vaccine were very low in both age were higher for both age groups, being 60% or more 
groups. being <SO% for the SENILIIICS and slightly with some exceptions. The numbers of serologically 
> 50%’ for the JUNII:UKS. The serological protection protcctcd subjects after vaccination with the HI N 1 and 
Table 2 HI titres after repeated vaccinafion 
HlNl Age” Dayb Anaiwan l/86” ATTaiwan/ la6 A/Taiwan/l 186 A/Taiwan/l/l a6 
NC 1 990d N 1991 N 1992 N 1993 
S 0 57 (1) 6 (5-6) 
21 44 (28-69)* 
J 0 43 (1) 6 (5-7) 
21 136 (99-l 87) 
S 0 
21 
J 0 
21 
S 0 
21 
J 0 
21 
40 (2) 21 (13-33)* 
47 (31-72) 
ia (2) 75 (41-137) 
ii8 (82-168) 
55 (1) 5 (5-6) 
1 a (13-27)* 
42 (1) 9 (6-12) 
105 (77- 142) 
26 (3) 26 (15%45)* 12 (4) 22 (12-40) 
46 (28-75) 37 (19-72) 
9 (3) a7 (35-219) 
100 (40-252) 
2a (2) 9 (6-14)* 17 (3) 20 (10-38) 
47 (30-74)** 31 (16-58)** 
14 (2) 45 (24-87) 
73 (42- 126) 
26 (1) 6 (5-7) 13 (2) 25 (g-67) 
57 (28-i 17)* a2 (33-203) 
3a (1) 15 (9-25) 
206 (149-284) 
H3N2 Age Day AIGuizhou/54/89 A/Beijingi353/89 AlBeijingi353la9 A/Beijing/32/92 
N 1990 N 1991 N 1992 N 1993 
S 0 57 (1) 16 (11-23) 
21 328 (227-474) 
J 0 43 (1) 21 (14-32) 
21 246 (187-324) 
S 
21 
J 0 
21 
S 0 
21 
J 0 
21 
40 (2) 114 (77-170) 
307 (207-454) 
ia (2) 68 (43-l 06) 
328 (192-562) 
55 (1) a (6-l 1) 
117 (67-206) 
42 (1) ii (a-17) 
261 (176-386) 
26 (3) 156 (103-236) 12 (4) 43 (18-102) 
273 (186-400) i 57 (58-429) 
9 (3) 156 (94-258) 
196 (109-353) 
2a (2) 67 (37m125)* 17 (3) 28 (14-59) 
308 (203-465) 624 (322-121 l)** 
14 (2) 209 (92-478) 
248 (107-575) 
26 (1) 9 (7-13) 13 (2) ia (a-39) 
I a6 (84-41 I) 1 a5 (80-425) 
3a (1) 14 (9-22) 
276 (169-452) 
Bl Age Day B/Yamagata/l6/88 B/Panama/45190 B/Yamagatall6/88 B/Panama/45190 
N 1990 N 1991 N 1992 N 1993 
S 0 57 (1) 6 (5-a) 
21 a2 (58-i i 7)* 
J 0 43 (1) 9 (6-12) 
21 232 (158-339) 
S 0 
21 
J 0 
21 
S 0 
21 
J 0 
21 
40 (2) 96 (60-151)* 26 (3) 122 (77-195) 12 (4) 230 (129-410) 
494 (346-706)** 315 (204-485)** 626 (341V1149)** 
ia (2) 291 (156-543) 9 (3) 218 (106-448) 
a72 (552-137a)** 371 (236-581)** 
55 (1) 16 (11-22) 2a (2) 15 (9-25) 17 (3) 167 (68-407) 
152 (94-244)* 333 (194-574)** 634 (336-1200)** 
42 (1) la (11-29) 14 (2) 145 (91-230) 
640 (460-889) 462 (303-703) 
26 (1) 6 (5-7) 13 (2) a2 (27-255) 
38 (20-73)* 1413 (682-2924)** 
3a (1) 9 (6-13) 
287 (160-513) 
82 Age Day B/Beijing/l/a7 
N 1990 
B/Beijing/l187 
N 1991 
S 0 
21 
J 0 
21 
S 0 
21 
J 0 
21 
57 (1) 14 (9-20) 40 (2) 75 (47- 120) 
177 (116-268) 252 (164-386) 
43 (1) 20 (12-34) Ia (2) 144 (66-312) 
290 (203-415) 366 (238-562) 
55 (1) 27 (17-44) 
233 (150-361)* 
42 (1) 22 (13-35) 
657 (400- 1080) 
Chronological listing of HI titres. Rows from left to right show cohorts starting in 1990, 1991 or 1992 respectively. Numbers of subjects 
decrease as a result of loss to follow up. In 1993 only SENIEURS were revaccinated 
“S, SENIEURS; J, JUNIEURS 
bDay 0 = prevaccination titre; day 21 = postvaccination titre 
‘Number of subjects (number of vaccinations received) 
dYear of vaccination 
“Vaccine strain 
Pre- and postvaccinahon HI titres GMT (95% confidence interval): *P<O.O5; Student’s t-test between titres of SENIEURS and JUNIEURS; 
**P ~0.05; paired t-test between current HI postvaccination titre and HI postvaccination titre in the previous year. Subjects due to loss to 
follow up were not considered in this analysis 
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Table 3 Serological protection rates after repeated vaccination 
NlNl Age” Dayb A/Taiwan/l 186’ A/Taiwan/l I86 AiTaiwanil I86 ATTaiwan/ I86 
NC 1990” N 1991 N 1992 N 1993 
S 0 
21 
J 0 
21 
S 0 
21 
J 0 
21 
S 0 
21 
J 0 
21 
57 (1) 2 40 (2) 15 
28* 30 
43 (1) 0 18 (2) 56 
63 56 
55 (1) 0 
13* 
42 (1) 2 
55 
26 (3) 19 12 (4) 0 
23* 17 
9 (3) 56 
67 
28 (2) 0 17 (3) 12 
32 24 
14 (2) 29 
50 
26 (1) 0 13 (2) 15 
31* 46 
38 (1) 21 
79 
H3N2 Age 
S 
J 
S 
J 
S 
J 
Day 
21 
0 
21 
0 
21 
0 
21 
0 
21 
0 
0 
21 
AlGuizhou/54/89 
N 1990 
57 (1) 12 
88 
43 (1) 14 
81 
AlBeijing 
N 1991 
40 (2) 45 
75 
18 (2) 33 
83 
55 (1) 2 
58* 
42 (1) 10 
79 
A/Beijing/353189 
N 1992 
26 (3) 73 
92 
9 (3) 78 
89 
28 (2) 36 
89** 
14 (2) 71 
79 
26 (1) 0 
58 
38 (1) 13 
76 
A/Beijing/32192 
N 1993 
12 (4) 25 
67 
17 (3) 24 
94 
13 (2) 15 
69 
Bl Age Day BNamagatall6188 BiPanama/45/90 B/Yamagatall6/88 BIPanamal45l90 
N 1990 N 1991 N 1992 N 1993 
S 0 
21 
J 0 
21 
S 0 
21 
J 0 
21 
S 0 
21 
J 0 
21 
57 (1) 0 42 (2) 35 
30* 85** 
43 (1) 0 18 (2) 61 
58 94** 
55 (1) 4 
45* 
42 (1) 12 
86 
26 (3) 27 12 (4) 58 
62** 92 
9 (3) 56 
89 
28 (2) 4 17 (3) 47 
64* 82 
14 (2) 36 
93 
26 (1) 0 13 (2) 31 
15* 92** 
38 (1) 0 
68 
82 Age Day B/Beijing/l/87 B/Beijing/l/87 
N 1990 N 1991 
S 0 57 (1) 7 40 (2) 28 
21 51* 60 
J 0 43 (1) 14 18 (2) 61 
21 72 83 
S 0 55 (1) 11 
21 51* 
J 0 42 (1) 7 
21 83 
Chronological listing of serological protection rates. Rows from left to right show cohorts starting in 1990, 1991 or 1992 respectively. 
Numbers of subjects decrease as a result of loss to follow up. In 1993 only SENIEURS were revaccinated 
S, SENIEURS; J, JUNIEURS 
bDay 0 = prevaccination titre; day 21 = postvaccination titre 
“Number of subjects (number of vaccinations received) 
‘Vaccine strain 
“Year of vaccination 
Pre- and postvaccination serological protection rates. Numbers are percentages of subjects with protective HI titre (HI > 100 for influenza 
A strains; HI > 200 for influenza B strains) 
*P < 0.02; z* test between serological protection rates of SENIEURS and JUNIEURS 
**P<O.O5’ McNemar test between current postvaccination serological protection rate and postvaccination serological protection rate in the 
previous year. Subjects due to loss to follow up were not considered in this analysis 
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B components show some differences between 
SENIEUKS and JUNIEUKS. In most cases the JUNIE~JRS 
reached higher serological protection rates than the 
SENIEUKS (Tahlr 3). 
DISCUSSION 
When SENIEUR young and elderly are vaccinated 
repeatedly with influenza vaccine no decline in anti- 
body formation or serological protection rate can be 
observed in this study. These data are in agreement 
with data published concerning annually repeated 
influenza vaccination in young or middle-aged 
persons’ l. The increase in the postvaccination HI titre 
against the influenza B strains as a result of annually 
repeated vaccination was also found by Howells et al.“. 
However, the SENI~UKS vaccinated for the first time 
in 1991 show some changes in the postvaccination 
titres against the HlNl strain reached after the second 
and third vaccination. The postvaccination titre rises 
significantly after the second vaccination in comparison 
with the first and declines again significantly after the 
third vaccination but remains higher than the titrc after 
the first vaccination. The rise after the second vaccina- 
tion could be explained in part by a poor antigenicity 
of the vaccine in 1991. as we found lower HI responses 
after vaccination in persons entering in 1991 than in 
those who were vaccinated in 1990 or 1992 for the first 
time. This HI titre rise in the SENI~UKS from 1991 after 
vaccination in 1992 was also seen for the H3N2 strain 
A/Beijing/353/89 though this was not statistically signi- 
ficant. However, as the titrc against the HlNl compo- 
nent decreases again after the third vaccination it is 
more likely that the fluctuations seen in this group arc 
a result of group related differences. 
The antibody formation after vaccination in 1902 
with BiYamagatail6188 seems to be lower than the HI 
titre against B/Panama/45190 in the previous year. 
However, the subjects still have a high amount of anti- 
body in 1992 to the vaccine strain of 1991. This lower 
antibody measurement against B/Yamagata/16/88 could 
be explained by a different avidity of B/Panama/45190 
in the HI test. 
The HI titre reached after vaccination was extrapo- 
lated to a measure of serological protection. The 
diminished protection after repeated vaccination found 
by Hoskins in schoolboys” was not found in the 
JUNIEURS and SENI~JRS of this study. Moreover, for 
the B strains the serological protection rates after the 
second vaccination were higher than after the tirst 
vaccination. The serological protection rates were 
calculated for the antibody production against the 
vaccine strains, whereas the antibody titres and sero- 
logical protection rates to the epidemic virus strains 
were not determined. Possibly the serological protec- 
tion rates given here might differ from the actual 
protection against a challenge with epidemic virusses. 
Longitudinal observation of postvaccination titres 
against influenza vaccine strains presents some difficul- 
ties. Because the composition of the vaccine changes 
every year and because of possible differences in sensi- 
tivity of these different strains in the HI test a 
comparison from one year to the other must be made 
with caution. When the vaccine strain changed from 
one year to another, in the case of the H3N2 and B 
components, the antibody response to the vaccine 
1328 Vaccine 1997 Volume 15 Number 12/l 3 
component of the previous year was also measured 
(data not shown). It appeared that this hctcrologous 
response was sometimes cvcn better than the rcsponsc 
to the vaccine strain. This anamnestic phenomenon has 
been described before” “’ and has to be taken into 
account when evaluating the response after rcpeatcd 
vaccination. 
When considering prc- and postvaccination HI titres 
in healthy cubjccts who had not hccn vaccinated 
against influenza for at lcast 2 years, several diffcrcnccs 
between JuNffxrfcs and Sfmffmfts occurred in the quan- 
titative antibody formation against influenza hacmag- 
glutinin. The finding that elderly showed a lower 
immune response to the A/Taiwan/l/86 (HI Nl) strain 
has been reported earlier’.” 1Z and our data concerning 
the diffcrcnces in the postvaccination HI titre are in 
agrecmcnt with data from McElhancy et ~1.“’ They 
found lower postvaccination HI antibody levels in 1990 
and 199 1 against the HlN 1 strain A/Taiwan/l/86 and 
the B strains BiYamagatail6188 and B/Panama/45/90 in 
S~NI~~IR cldcrly and young subjects of the same age 
groups as ours with the same vaccine strains as in our 
study in 1990 and 1991. They also found no diffcrcncc 
in postvaccination HI titrcs against the H3N2 strains 
between the two age groups. 
A diminished HI antibody response in the cldcrly 
has been reported before in other studies, but also 
equal or even higher antibody responses have been 
reported”. With regard to the results of this study we 
may conclude that in the absence of biases like differ- 
enccs in the prcvaccination titre, underlying disease 
and USC of drugs, there is an age-related, vaccine 
strain-dependent difference in HI antibody formation 
after influenza vaccination. 
It was suggested that the phenomenon of original 
antigenic sin may explain age-related differences in the 
antibody responses bctwccn the HINI and H3N2 
vaccine strains”‘.“. The S~NIWRS would be optimally 
primed for the strains of the HlNl subtype that circu- 
lated during their childhood. whereas the JUNII.UKS 
wcrc primed for Hl-strains closer rclatcd to the 
current HlNl strains. This could result in an 
age-related altered response to later influenza strains 
of the Hl subtype”. In contrast, the S~NIIXJKS would 
not have been exposed to the H3N2 subtype until the 
late sixtics, resulting in an equal exposure to viruses of 
the H3N2 subtype for both age groups. 
CONCLUSIONS 
There was no decline of HI antibody to the vaccine 
strains after annually repeated vaccination in SENIEURS 
and JUNIE~JRS. Moreover, for the B strains a second 
vaccination resulted in an even higher postvaccination 
titrc against the vaccine strain. Also the serological 
protection rates after annually repeated vaccination 
showed no decline. Thus annual influenza vaccination 
has proved to be effective in maintaining an adequate, 
protective HI antibody titre against the vaccine strains. 
The results of this study demonstrate an association 
between high age and a declined responsiveness to 
some influenza vaccine strains, but whether this is a 
true senescence phenomenon requires further investi- 
gation, as WC did not see this decrease for all vaccine 
strains. 
Annually repeated influenza vaccination and Hi the in SENIEUR elderly: /.A. de Bruijn et al. 
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